Featuring leading academic and clinical experts, the conversation will frame recent progress through unmet patient need, platform potential, regulatory clarity, and expedited designations across GI indications that underpin an efficient path toward registration. Panelists will discuss how pelareorep may enable value creation across indications and partnership opportunities as the field advances.
May 28, 2026